Big Pharma

Despite running into trouble this year, drugmaker, Mallinckrodtt, has been increasing its lobbying efforts in Congress.

CEOs are incentivized not to take actions that would benefit the healthcare system overall, but rather to “inflate stock prices.”

Bayer and Syngenta asked scientists for raw data on a major new study which found that neonicotinoid pesticides cause harm to bees.

Trump's planned executive order on drug pricing goes out of its way to end existing discounts to low-income people.

Dr. Andrew Kolodny, co-director of opioid policy research at Brandeis University, discusses how Big Pharma contributes to the ongoing opioid crisis.

Leaders of the private health industry want you to look elsewhere while they help write the Senate version of Trumpcare.

Medications are a vital need like electricity, water and gas; it's time to recognize them as a public utility.

Environmental standards do not feature in international regulations governing drug production.

Increase access to generics, end “evergreening” drug patents, and other ways to put people before profits.